Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40‐TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage
暂无分享,去创建一个
S. Korsmeyer | Jeffrey E. Green | M. Knudson | K. Yoshidome | Masatoshi Shibata | Min-ling Liu | E. Shibata | Tabassum Bandey | Min-ling Liu
[1] E. White,et al. Interaction of E1B 19K with Bax is required to block Bax-induced loss of mitochondrial membrane potential and apoptosis , 1998, Oncogene.
[2] S. Korsmeyer,et al. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis , 1998, The EMBO journal.
[3] L. Wakefield,et al. Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency , 1998, Nature Medicine.
[4] W. Yung,et al. Overexpression of E2F‐1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo , 1998, Nature Medicine.
[5] J. Green,et al. Reduced p53 dosage associated with mammary tumor metastases in C3(1)/TAG transgenic mice , 1997, Molecular carcinogenesis.
[6] S. Korsmeyer,et al. Bax suppresses tumorigenesis and stimulates apoptosis in vivo , 1997, Nature.
[7] J. Ward,et al. p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: suppression of apoptosis during the transition from preneoplasia to carcinoma. , 1996, Cancer research.
[8] John Calvin Reed,et al. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. , 1996, The American journal of pathology.
[9] E. White,et al. The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. , 1996, Genes & development.
[10] E. White,et al. Life, death, and the pursuit of apoptosis. , 1996, Genes & development.
[11] S. Korsmeyer,et al. Bax-Deficient Mice with Lymphoid Hyperplasia and Male Germ Cell Death , 1995, Science.
[12] K. Franssila,et al. Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. , 1995, Cancer research.
[13] Z. Oltvai,et al. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[14] Matthew J. Brauer,et al. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak , 1995, Nature.
[15] G. Evan,et al. Induction of apoptosis by the Bcl-2 homologue Bak , 1995, Nature.
[16] S. Korsmeyer,et al. Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death , 1995, Cell.
[17] John Calvin Reed,et al. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.
[18] J. Green,et al. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[19] John Calvin Reed,et al. Immunohistochemical analysis of in vivo patterns of Bcl-X expression. , 1994, Cancer research.
[20] C. Harris,et al. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.
[21] John Calvin Reed,et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. , 1994, Oncogene.
[22] Z. Oltvai,et al. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax , 1994, Nature.
[23] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[24] S. Elledge,et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.
[25] C. Thompson,et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.
[26] S. Korsmeyer,et al. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.
[27] W. Willett,et al. Breast cancer (2). , 1992, The New England journal of medicine.
[28] A. Kimchi,et al. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 , 1991, Nature.
[29] R. Schreiber,et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death , 1990, Nature.